US Stock MarketDetailed Quotes

EWTX Edgewise Therapeutics

Watchlist
  • 33.000
  • +0.800+2.48%
Close Nov 29 13:00 ET
  • 33.000
  • 0.0000.00%
Post 17:01 ET
3.12BMarket Cap-22000P/E (TTM)

Edgewise Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Edgewise Therapeutics Q3 2024 Earnings Date

Currency：USDNov 7, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.37
-0.36
+0.01
Beat Est.
+8.64%
+12.20%
+3.87%
Analyst Rating
Strong Buy

Nov 30, 2024

Edgewise Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 7, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 7, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Edgewise Therapeutics Earnings Reports

  • Edgewise Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 08:13 ET

  • Edgewise Therapeutics | 8-K: Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

    Nov 7 08:03 ET

  • Edgewise Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 08:09 ET

  • Edgewise Therapeutics | 8-K: Edgewise Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

    Aug 8 08:04 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data